HARVARD BIOSCIENCE INC — Director's Dealing 2018

Nov 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2018-11-26

Reporting Person: Unninayar Kamalam (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-26	Common Stock	A	18469	$0.00	Acquired	18469	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-26	Stock option (right to buy)	$3.79	A	44585	Acquired	2028-11-26	Common Stock, par value $0.01 per share (44585)	Direct

Footnotes

F1: Represents a deferred stock award of restricted stock units which shall vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.

F2: Includes a deferred stock award of 18,469 restricted stock units which vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.

F3: This stock option vests in four equal annual installments on November 1, 2019, 2020, 2021 and 2022.